The primary purposes of this framework are to: 1) promote, enhance, and intensify TB research and innovation at the country level, and 2) promote, enhance, and catalyze TB research at the global level through advocacy, innovation, discussion of global priorities, and the development of networks for research and capacity building.

This document provides practical guidance on translating the World Health Organization's principles and recommendations into a national or local screening strategy.

This document highlights strategic directions to integrate digital health into TB prevention and care activities in support of WHO’s End TB Strategy.

This is the 20th global report on tuberculosis (TB) published by WHO in a series that started in 1997. It provides a comprehensive and up-to-date assessment of the TB epidemic and progress in implementing and financing TB prevention, care and control at global, regional and country levels using data reported by 200 countries and territories that account for over 99% of the world’s TB cases.

This facilitators’ guide for training community health workers and community volunteers is intended for training in tuberculosis (TB) and integration of TB prevention and care services into community-based activities.

This document presents guidance on the design and implementation of surveys and surveillance systems to measure the burden and trends of drug-resistant tuberculosis.

The objectives of this document are to describe the best practices in engaging different health providers and partners in the management of drug-resistant TB patients and to describe the necessary components in planning and implementing a public-private mix for the management of drug-resistant TB.

This document provides a generic framework for implementing TB diagnostics. Topics covered include managerial, technical, and operational processes required for developing and implementing a national strategy for TB laboratories.

This toolkit was developed to help National TB Program managers and others involved in the management of TB programs develop new National Strategic Plans or improve existing ones.

The purpose of these guidelines is to provide guidance on evidence-based practices for testing, treating and managing latent TB infection (LTBI) in persons who are at the highest risk of progressing to active TB disease. Specific objectives include identifying and prioritizing at-risk groups for targeted testing and treatment and recommending specific treatment options.